On November 18, Liu Anmin, deputy general manager of China Automotive Engineering Research Institute Co., Ltd. (hereinafter referred to as China Automotive Research Institute) and Professor Yi Huiyong visited Shineway for research and guidance. Dr. Gao Yibo, general manager of our company, Dr. Song Qi, R&D director, Dr. Fang Yaying, marketing director and Mr. He Xiaoding, production director, extended a warm welcome to deputy general manager Liu and his party, And connected Professor Wen Weijia of Hong Kong University of science and Technology (Chairman of Shineway) for online communication. The two sides jointly discussed the possibility of cooperation.
Shineway management took a group photo with vice president Liu and Professor Yi of Automotive Research Institute.
At the meeting, Dr. Gao Yibo introduced the existing microfluidic chip PCR nucleic acid detection technology and products of Shineway to Liu Anmin, vice president of China Automotive Research Institute and Professor Yi Huiyong. Dr. Fang Yaying, marketing director, introduced and analyzed the market of mobile PCR nucleic acid detection laboratory, and then, Professor Wen Weijia, chairman of the board of directors, introduced the existing R&D strength and scientific and technological transformation of the Hong Kong University of science and technology. Liu Anmin, vice president of China Automotive Research Institute and Professor Yi Huiyong introduced the purpose of this research and guidance, and highly agreed that the mobile PCR nucleic acid detection laboratory project using POCT detection equipment has great development prospects and broad market space. At the same time, they hope that the two sides will strengthen cooperation and fully promote R&D and product development, The two sides work together to open up a broad emerging market for mobile nucleic acid detection and contribute to the normalization of epidemic prevention and control.
After the meeting, Dr. Gao Yibo introduced the development process of Shineway to Vice President Liu and Professor Yi in the co-construction exhibition hall of the Blue Bay Incubation Port of Hong Kong University of Science and Technology, and showed our company's existing microfluidic chip PCR Nucleic Acid Analyzer. In-depth exchanges were conducted on the deep integration of the in vitro molecular diagnostic industry and the automotive industry.
Dr. Gao Yibo introduced products to visitors in the blue bay exhibition hall
At the beginning of 2020, the outbreak of COVID-19 epidemic made "nucleic acid detection" well known, and the demand for nucleic acid detection instruments increased rapidly; Judging from the normalization policy of epidemic prevention and control issued by the state and the spread trend of overseas epidemic, the "nucleic acid detection" market will continue to grow. How to find the infected person early and reduce the infection rate is the most critical link in the epidemic prevention and control.
Mobile PCR nucleic acid testing laboratory can alleviate the shortage of equipment during the epidemic, implement the measures of "early detection, early report, early isolation and early treatment", meet the needs of emergency testing, avoid the large-scale flow of subjects and reduce the infection rate. At present, Shineway has independently developed a PCR nucleic acid detection analyzer that can be used in clinic. The silicon-based microfluidic chip technology is the first in China and exported to many countries and regions at home and abroad.
Microfluidic chip PCR Nucleic Acid Analyzer independently developed by Shineway (left) and its microfluidic chip (right)
For a long time, Shineway takes "Technology, shine the way of health" as its own responsibility, and is committed to achieving the goal of early detection and treatment of diseases through science and technology. The cooperation with the Automobile Research Institute is a win-win breakthrough in the cooperation between Shineway and the leading domestic automobile leading enterprises. We hope to explore a new path in China's in vitro diagnosis industry.
